PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'CEMAD - IBD UNIT - Unitá Operativa Complessa di Medicina Interna e Gastroenterologia, c Fondazione Policlinico Universitario \'A. Gemelli\' IRCCS, Rome, Italy.\', \'Dipartimento Universitario di Medicina e Chirurgia Traslazionale, Università Cattolica del Sacro Cuore, Rome, Italy.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1177/2050640620929133
?:doi
?:hasPublicationType
?:journal
  • United European gastroenterology journal
is ?:pmid of
?:pmid
?:pmid
  • 32438878
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.145
?:rankingScore_hIndex
  • 20
is ?:relation_isRelatedTo_publication of
?:title
  • Impact of COVID-19 pandemic on the daily management of biotechnological therapy in inflammatory bowel disease patients: Reorganisational response in a high-volume Italian inflammatory bowel disease centre.
?:type
?:year
  • 2020

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/32438878>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/32438878>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all